Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination — Stella

View on ClinicalTrials.gov

Recruiting

Back to Hpv trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Rochester Medical Center (URMC), Rochester, New York

Key details

Sponsor

University of Rochester

Collaborators

National Institutes of Health (NIH), National Cancer Institute (NCI)

Enrollment target

~16,000 participants

Started

November 2024

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

9 Years – 17 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.